CI vs PLRX · P/E 2.4, rev $274.90B vs $77.3M cap
Cigna Corp (CI) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the CI and PLRX stock pages for the full models.
Not investment advice.